Emma Fiorini

Title: Emma Fiorini: Innovator in Therapeutic Vaccines

Introduction

Emma Fiorini is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of therapeutic vaccines, particularly in the development of innovative solutions for amyloid-beta associated diseases. With a total of 2 patents, her work is paving the way for advancements in cognitive health.

Latest Patents

Emma Fiorini's latest patents focus on anti-abeta therapeutic vaccines. These liposomal vaccine compositions comprise a β-amyloid (Aβ)-derived peptide antigen displayed on the surface of the liposome. The vaccine also includes a peptide with a universal T-cell epitope encapsulated within the liposome, along with an adjuvant that may form part of the liposome and be displayed on its surface. These compositions are designed to treat, prevent, and induce a protective immune response against symptoms associated with amyloid-beta related conditions, particularly those affecting cognitive memory capacity. The vaccine compositions may also be provided as a kit, along with related methods for producing the liposomal vaccine composition.

Career Highlights

Emma Fiorini is currently associated with Ac Immune SA, a company known for its focus on innovative therapeutic solutions. Her work has been instrumental in advancing the understanding and treatment of cognitive diseases, showcasing her dedication to improving patient outcomes.

Collaborations

Emma collaborates with talented professionals in her field, including Marija Vukicevic Verhille and Maria Pihlgren Bosch. These collaborations enhance the research and development efforts at Ac Immune SA, contributing to the innovative landscape of therapeutic vaccines.

Conclusion

Emma Fiorini stands out as a leading inventor in the realm of therapeutic vaccines, with her innovative approaches addressing critical health challenges. Her contributions are vital for the future of cognitive health treatments.